This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Mylan-Lamotrigine - 150 mg
- Starting date:
- May 25, 2013
- Posting date:
- June 6, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety, Quality
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-33935
Recalled products
- Mylan-Lamotrigine - 150 mg
Reason
Quality concerns at the manufacturing facility of the active ingredients used in the products.
Depth of distribution
Product distributed to wholesalers and pharmacies within Canada
Affected products
A. Mylan-Lamotrigine - 150 mg
DIN, NPN, DIN-HIM
DIN 02265516
Dosage form
- Tablets
Strength
- 150 mg
Lot or serial number
- 1053179 (100 count)
- 1066559 (100 count)
- 1066560 (100 count)
- 1066561 (100 count)
- 1089653 (100 count)
- 1089654 (100 count)
Companies
- Recalling Firm
-
Mylan Pharmaceuticals ULC
85 Advance Road
Etobicoke
M8Z 2S6
Ontario
CANADA
- Marketing Authorization Holder
-
Mylan Pharmaceuticals ULC
85 Advance Road
Etobicoke
M8Z 2S6
Ontario
CANADA